drugset / Trial / NCT03586674

Fibrates in Pediatric Cholestasis

NCT03586674

Phase 2 Completed 50 enrolled Hoda A. Atta
Non-randomizedParallel-groupOpen-labelTreatment

Summary

A study conducted to assess the effect of fibrates on pruritus and biochemical picture in pediatric patients with cholestatic liver diseases.

Timeline

Start
2017-11-01
Primary completion
2018-06-01
Completion
2018-06-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenofibrate Small molecule 10 mg/kg Oral
Subject Fenofibrate Small molecule 20 mg/kg Oral
Background Ursogal Unknown 10 mg/kg Oral
Background Ursogal Unknown 20 mg/kg Oral

Indications